TPSAC Representative Urges Manufacturers to Share Their Concerns

The FDA's Tobacco Products Scientific Advisory Committee (TPSAC) will be making recommendations over the next few months that will likely have an adverse impact on the business of small tobacco manufacturers. The next TPSAC meetings are on June 8-9 and July 15-16. The meeting materials and other relevant information are available http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommittee. Dr. John H. Lauterbach, who represents the interests of small tobacco manufacturers on the committee, is urging small manufacturers to share their concerns with him. Dr. Lauterbach can be reached at 478 474 8818 (office) or at 478 731 2966 (cell phone). His e-mail address for TPSAC business is lauterba@bellsouth.net. Dr. Lauterbach's responsibilities on the TPSAC are separate and distinct from his consulting business on tobacco chemistry, toxicology, and FDA regulation of tobacco products. Enditem